These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 6495266

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Antithrombin III "Northwick Park": a variant antithrombin with normal affinity for heparin but reduced heparin cofactor activity.
    Howarth DJ, Samson D, Stirling Y, Seghatchian MJ.
    Thromb Haemost; 1985 Jun 24; 53(3):314-9. PubMed ID: 4049307
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Elimination of high affinity heparin fractions and their anticoagulant and lipase activity.
    de Swart CA, Nijmeyer B, Andersson LO, Holmer E, Verschoor L, Bouma BN, Sixma JJ.
    Blood; 1984 Apr 24; 63(4):836-42. PubMed ID: 6704544
    [Abstract] [Full Text] [Related]

  • 10. The interaction of heparin with plasma proteins. Demonstration of different binding sites for antithrombin III complexes and antithrombin III.
    McKay EJ, Laurell CB.
    J Lab Clin Med; 1980 Jan 24; 95(1):69-80. PubMed ID: 7350242
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Contribution of red blood cells to the saturable mechanism of heparin clearance.
    Young E, Hirsh J.
    Thromb Haemost; 1990 Dec 28; 64(4):559-63. PubMed ID: 2084941
    [Abstract] [Full Text] [Related]

  • 14. Comparative turn-over of heparin cofactor II and antithrombin III in baboons. Influence of heparin and pentosan polysulfate administration.
    Sié P, Lansen J, Lacheretz F, Verschuere B, Boneu B.
    Thromb Haemost; 1986 Dec 15; 56(3):302-7. PubMed ID: 2436331
    [Abstract] [Full Text] [Related]

  • 15. [Antithrombin III activity in relation to multiple administration of various doses of heparin to normal animals].
    Kudriashov BA, Pastorova VE, Liapina LA.
    Vopr Med Khim; 1985 Dec 15; 31(3):37-41. PubMed ID: 4024529
    [Abstract] [Full Text] [Related]

  • 16. Effect of individual carbohydrate chains of recombinant antithrombin on heparin affinity and on the generation of glycoforms differing in heparin affinity.
    Olson ST, Frances-Chmura AM, Swanson R, Björk I, Zettlmeissl G.
    Arch Biochem Biophys; 1997 May 15; 341(2):212-21. PubMed ID: 9169007
    [Abstract] [Full Text] [Related]

  • 17. Studies of heparin affinity to antithrombin III and other proteins in vitro and in vivo.
    Takeda Y, Kobayashi N.
    Thromb Haemost; 1977 Oct 31; 38(3):685-95. PubMed ID: 579514
    [No Abstract] [Full Text] [Related]

  • 18. Heparin elimination in patients with liver cirrhosis.
    Teien AN.
    Thromb Haemost; 1977 Oct 31; 38(3):701-6. PubMed ID: 579516
    [Abstract] [Full Text] [Related]

  • 19. Turnover study of heparin cofactor II in healthy man.
    Sié P, Dupouy D, Pichon J, Boneu B.
    Thromb Haemost; 1985 Oct 30; 54(3):635-8. PubMed ID: 3841420
    [Abstract] [Full Text] [Related]

  • 20. Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration.
    Collen D, Schetz J, de Cock F, Holmer E, Verstraete M.
    Eur J Clin Invest; 1977 Feb 30; 7(1):27-35. PubMed ID: 65284
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.